Tobramycin Solution
Product Images NDC 68180-962

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 68180-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 01

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 02

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 03

The text describes a figure showing the absolute change from baseline in logarithmic colony-forming units (CFUs). The figure includes data from two studies, Study 1 and Study 2, both of which included a placebo treatment. In Study 1, the treatment was Tobramycin Inhalation Solution, while in Study 2, the treatment was Tobramycin Inhalation Solution with Nhalaton Solution. The meaning or context of the numbers "16" and "2" is not clear from the given text.*

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 04

The text is not complete and does not provide enough context to generate a useful description.*

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 05

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 06

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 07

The text provides a diagram with a nebulizer cup, a mouthpiece, and an inspiratory valve cap marked as Figure D. No additional information is available.*

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 08

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 09

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 10

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 11

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 12

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 13

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 14

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 15

This appears to be a simple list describing a nebulizer device, including a mouthpiece and a nebulizer cup. No further context or information is available.*

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 16

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 17

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 18

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 19

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 20

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 21

This is a description of Tobramycin Inhalation which is a solution (300 mg/5mL) containing Tobramycin that is only intended for inhalation through a nebulizer. Each package contains four single-dose ampules that do not contain preservatives. Each 3mL ampule provides a 300 mg dose of Tobramycin and 1125 mp of Sodium Chloride in Sterile Water for Injection. The solution must only be used with the required form of nebulizer. Additionally, it should be stored in a refrigerator at 2-8°C. The product is available only through prescription. For more information, you can contact 18003992561.*

FDA Label Image

9d1a642e 5e3f 4b37 94dd F275a538ba21 22

Tobramycin Inhalation Solution, USP is supplied in 300 mg/ 5 mL ampules that can be used for inhalation only by nebulizer. It contains no preservatives and is stored in a refrigerator. The box comes with 56 Single-Dose Ampules that can be used for 28-day supply. Each ampule contains 300 mg dose of Tobramycin and requires the use of the required nebulizer specified in the package insert for prescribing information. For more information, call 1-800-825-8746.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.